Dr. Nagendra G-Drug Discovery and Development-Best Researcher Award

REVA University-India

Author Profile `

• Scopus 
• Google Scholar

Early Academic Pursuits

Dr. Nagendra Govindappa embarked on his academic journey with a strong inclination towards chemistry, which led him to pursue a Ph.D. at Bangalore University under the mentorship of Dr. V. V. Sureshbabu. His doctoral research focused on the design and synthesis of novel peptidomimetics and related intermediates. Noteworthy achievements during this period include the insertion of thioamide linkage into peptide backbones and the synthesis of isoselenocyanates for the development of selenourea peptidomimetics. These endeavors laid the groundwork for his subsequent contributions to the field of peptide chemistry.

Professional Endeavors

Following his doctoral studies, Dr. Nagendra Govindappa continued his academic journey as an Associate Professor at REVA University, Bangalore. He expanded his research horizons through collaborations with esteemed institutions such as CSIR-IICT, Hyderabad, and TUD, Germany. His tenure at these institutions further enriched his expertise in synthetic chemistry, natural product synthesis, and chemical biology. Notable projects include the total synthesis of Cyclosporin-O, development of one-pot protocols for glycopeptide synthesis, and the synthesis of anti-cancer agents targeting EGFR family proteins.

Contributions and Research Focus

Dr. Nagendra Govindappa's research primarily revolves around the design, synthesis, and evaluation of peptides and peptidomimetics with diverse functionalities. He has pioneered the incorporation of various heterocycles such as oxadiazole, thiadiazole, tetrazole, and thiopeptides into peptide scaffolds, thereby expanding the chemical space of peptidomimetics. His innovative approaches have enabled the synthesis of bioactive molecules with potential applications in drug discovery and material science. Currently, he is focused on the total synthesis of natural peptides using advanced synthetic strategies and nanocatalysis.

Accolades and Recognition

Dr. Nagendra Govindappa's contributions to the field of peptide chemistry have garnered widespread recognition. He has published over 30 research articles in reputed journals, including notable contributions to journals with high impact factors. His research has been cited extensively, as evidenced by his impressive h-index of 12. Additionally, he holds two patents, underscoring the innovative nature of his work. His editorial appointments and professional memberships further signify his standing in the scientific community.

Impact and Influence on Drug Discovery and Development

Dr. Nagendra Govindappa's research has made significant contributions to the synthesis and functionalization of peptides and peptidomimetics. His work has not only expanded the synthetic toolbox available to chemists but has also provided insights into the structure-activity relationships of bioactive molecules. Moreover, his collaborations with international research groups have facilitated knowledge exchange and fostered scientific advancements on a global scale. His efforts have thus had a profound impact on the fields of chemistry and pharmaceutical sciences.

Legacy and Future Contributions

As Dr. Nagendra Govindappa continues his academic journey, his legacy is poised to endure through his impactful research and mentorship. His innovative approaches to peptide synthesis and his dedication to advancing the frontiers of chemical biology serve as an inspiration to aspiring scientists. Moving forward, he aims to further explore the potential of peptidomimetics in drug discovery and materials science while nurturing the next generation of researchers through mentorship and collaboration. His unwavering commitment to scientific excellence ensures that his contributions will continue to shape the landscape of chemical research for years to come.

Drug discovery and development is a complex and multifaceted process aimed at identifying, synthesizing, and bringing to market new medications to address unmet medical needs or improve upon existing treatments. The process typically begins with target identification, where scientists pinpoint specific molecules, proteins, or pathways involved in a disease process that could serve as potential therapeutic targets. Once a target is identified, researchers embark on the drug discovery phase, which involves screening large libraries of compounds to find molecules that interact with the target in a desired way. This phase often employs techniques such as high-throughput screening and computer-aided drug design to identify promising lead compounds, which undergo further optimization to enhance their potency, selectivity, and pharmacokinetic properties.

Notable Publication 

• An expedient route for the synthesis of an anti-HIV peptide Kn2-7: A TAG approach
• Ultrasound-accelerated Synthesis of N-protected Amino Alkyl Iodides from Amino Alcohols Using P2 I4 Reagent and its Application in the Synthesis of Amino Alkyl Thiols
• Synthesis and biological evaluation of amide derivatives of the quinazoline tethered (pyridyl)-1,2,4-thiadiazoles as anticancer agents
• Synthesis and Biological Evaluation of 2-Aminothiazole Analogues of Nα-Protected Amino Acids